Wafra Inc. Edwards Lifesciences Corp Transaction History

Wafra Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $99,914 - $130,142	1,213 Added 1.0%	122,973 $10.2 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $31.1 Million - $46.2 Million	-359,822 Reduced 74.72%	121,760 $11.6 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $347,989 - $438,024	3,413 Added 0.71%	481,582 $56.7 Million
Q4 2021 Feb 17, 2022	SELL	$106.37 - $130.68 $27.1 Million - $33.3 Million	-254,617 Reduced 34.75%	478,169 $61.9 Million
Q3 2021 Nov 08, 2021	SELL	$102.91 - $122.75 $884,511 - $1.06 Million	-8,595 Reduced 1.16%	732,786 $83 Million
Q2 2021 Aug 06, 2021	BUY	$83.84 - $104.76 $755,482 - $943,992	9,011 Added 1.23%	741,381 $76.8 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $19.1 Million - $22 Million	242,843 Added 49.61%	732,370 $61.3 Million
Q4 2020 Feb 11, 2021	BUY	$71.69 - $91.23 $3.61 Million - $4.59 Million	50,350 Added 11.46%	489,527 $44.7 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $5.23 Million - $6.81 Million	77,846 Added 21.54%	439,177 $35.1 Million
Q2 2020 Aug 04, 2020	BUY	$57.54 - $76.95 $20.8 Million - $27.8 Million	361,331 New	361,331 $25 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Wafra Inc., based on Form 13F filings with the SEC.

Stay updated on Wafra Inc. with notifications on news.